Abruptio Placentae
Information
- Disease name
- Abruptio Placentae
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00014989 | Completed | Phase 3 | Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial) | December 1997 | June 2007 |
| NCT00186069 | Completed | N/A | Magnesium Sulfate vs Placebo for Placental Abruption | March 2004 | November 2017 |
| NCT01068795 | Completed | N/A | Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome | July 2009 | August 2015 |
| NCT01279369 | Terminated | The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta | October 2009 | October 2012 | |
| NCT03782168 | Terminated | Plasma Concentration of Biological Markers in Placental Abruption | January 31, 2019 | August 1, 2021 | |
| NCT04558996 | Unknown status | Spanish Registry of Pregnant Women With COVID-19 | March 1, 2020 | March 31, 2021 | |
| NCT01501890 | Withdrawn | N/A | Progesterone for First Trimester Vaginal Bleeding | January 2012 | September 2014 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D000037